Avricore Health Inc V.AVCR

Alternate Symbol(s): AVCRF

Technology Diagnostics & Research Information Technology Services

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

TSXV:AVCR - Post by User

Avricore Health Inc > Q1

<< Previous

Bullboard Posts

Next >>

Post by lscfaon Jun 01, 2023 12:44am

340 Views

Post# 35474178

Q1

No bloody explanation why revenues are down when devices deployed is up.

	Devices
Qtr ending	Deployed	Revenue	Gross Profit	Margin	Cash expenses	Cfo
Q1 23	532	629,241	210,681	33.5%	235,940	(25,259)
Q4 22	416	977,235	168,845	17.3%	83,937	84,908
Q3 22	166	572,228	215,961	37.7%	262,632	(46,671)
Q2 22	53	176,175	56,874	32.3%	233,103	(176,229)
Q1 22	53	42,736	15,113	35.4%	172,113	(157,000)
Q4 21	20	35,190	9,317	26.5%